Trial Profile
Phase 1, Open-label, Cross-over Study to Investigate the Relative Bioavailability of Pyramax (Pyronaridine-artesunate) in Tablet and Granule Formulations, in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Dec 2023
Price :
$35
*
At a glance
- Drugs Artesunate/pyronaridine (Primary)
- Indications COVID 2019 infections; Malaria
- Focus Pharmacokinetics
- Sponsors Shin Poong Pharmaceutical
- 21 May 2014 New trial record